BofA/Merrill Lynch Downgrades NuVasive (NUVA) to Underperform
Tweet
Share
E-mail
Get Alerts NUVA Hot Sheet
Price: $39.75 --0%
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
BofA/Merrill Lynch downgraded NuVasive (NASDAQ: NUVA) from Neutral to Underperform with a price target of $56.00.
Analyst Bob Hopkins says the company has been struggling to deliver differentiated growth on consistent basis for several quarters and is therefore incrementally more negative on the business.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $52.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Mobility Global (MBGL) at Neutral
- Adient amends credit deal, adds $500M in incremental term loans
- BofA maintains underperform ratings on six BDC stocks
Create E-mail Alert Related Categories
Analyst Comments, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
